Dr. Lipika Roy

Dr. Lipika Roy – Anesthesiologist & ICU Specialist, Khulna

Dr. Lipika Roy is a Consultant of ICU, HDU & Anesthesia at Shaheed Shaikh Abu-Naser Specialized Hospital, Khulna, with over 12 years of distinguished clinical, academic, and critical care experience. As an eminent Anesthesiologist and Intensive Care Specialist, she provides expert care for the most severe and complex perioperative conditions, uniquely focusing on highly volatile surgical scenarios and rare metabolic emergencies such as pseudocholinesterase deficiency, carcinoid crises, acute porphyria, and massive burn resuscitation. Patients requiring high-risk surgical anesthesia or life-saving ICU management receive evidence-based treatments tailored to ensure intraoperative safety, manage acute life-threatening physiological shifts, and achieve stable recovery. Her medical practice combines high-precision anesthetic delivery with individualized, multidisciplinary critical care plans.

Professional Biography

Dr. Lipika Roy completed her MBBS degree, establishing a comprehensive clinical foundation in general medical sciences. Demonstrating a profound commitment to critical care and perioperative medicine, she pursued highly rigorous postgraduate specialization, earning her Doctor of Medicine (MD) in Anesthesiology. To further apex her expertise in managing the most critically ill patients, she completed Special Training in ICU, HDU (High Dependency Unit), and PCM (Pain Control Management). This premier clinical qualification equips her with the advanced medical and physiological expertise required to safely anesthetize high-risk neonates with congenital defects, manage complex life-support machines, and orchestrate massive fluid resuscitation in severe burn victims. Finding the best Anesthesiologist and ICU Specialist in Khulna leads patients to rely on her 12+ years of dedicated clinical expertise at Khulna's premier specialized hospital.

Her primary clinical focus includes life-saving alternative muscle relaxant protocols and prolonged ventilator support for pseudocholinesterase deficiency, precise octreotide administration and hemodynamic control for carcinoid crises, meticulously tailored anesthetic drug selection to prevent porphyria crises, extreme temperature and fluid regulation for severe burns, and ultra-delicate airway management for neonatal congenital surgeries. Her diagnostic framework incorporates advanced preoperative risk stratification, continuous invasive hemodynamic monitoring, and targeted intensive care assessments to formulate effective, safe surgical and survival strategies.

At-a-Glance Profile Card

Qualifications & Education

• MBBS – Bachelor of Medicine and Bachelor of Surgery

• MD (Anesthesiology) – Doctor of Medicine in Anesthesiology

• Special Training – ICU (Intensive Care Unit), HDU (High Dependency Unit) & PCM (Pain Control Management)

Designation & Workplace

• Designation: Consultant, ICU, HDU & Anesthesia

• Workplace: Shaheed Shaikh Abu-Naser Specialized Hospital, Khulna

Diseases & Conditions Managed

• Pseudocholinesterase deficiency requires specialized muscle relaxant avoidance and prolonged mechanical ventilation.

• Neonatal congenital surgeries demand ultra-precise pediatric anesthesia and delicate airway management.

• Porphyria crisis perioperative management requires strict avoidance of triggering anesthetic agents (e.g., barbiturates).

• Severe burn management needs massive fluid resuscitation, thermoregulation, and complex pain control in the ICU.

• Carcinoid crisis demands rapid administration of octreotide and precise hemodynamic control during tumor excision.

• Acute Respiratory Distress Syndrome (ARDS) requires advanced mechanical ventilation and prone positioning.

• Sepsis and Septic Shock demand intensive care unit (ICU) hemodynamic support and vasopressors.

• Traumatic Brain Injury (TBI) requires neuroprotective anesthesia and strict intracranial pressure monitoring.

• Multi-organ dysfunction syndrome (MODS) needs comprehensive life-support integration (dialysis, ventilation).

• High-risk obstetric emergencies (Eclampsia/Hemorrhage) demand rapid-response surgical anesthesia and ICU care.

Clinical Specialties & Treatment Areas

• Advanced Intensive Care (ICU/HDU): Precision management of critically ill adults and children facing multi-organ failure, severe burns, or massive trauma, ensuring 24/7 physiological stability and life support.

• Rare Metabolic & Genetic Anesthesia: Expert delivery of specialized anesthetic care for patients with hidden genetic defects (Pseudocholinesterase deficiency, Porphyria) that make standard anesthesia lethal.

• Neonatal & High-Risk Surgical Anesthesia: Rapid-response, life-saving interventions for infants born with severe congenital defects requiring immediate, highly delicate surgical reconstructions.

Advanced Procedure Breakdown

Carcinoid Crisis Management

Carcinoid tumors (neuroendocrine tumors) secrete massive amounts of serotonin and histamine. The moment a surgeon touches the tumor during removal, these chemicals flood the bloodstream, causing a "carcinoid crisis"—a lethal combination of plunging blood pressure, severe wheezing (bronchospasm), and heart failure. Dr. Roy orchestrates a meticulous, highly volatile anesthetic plan, preemptively administering specialized drugs like Octreotide to block the hormones and instantly controlling massive blood pressure swings.

Prolonged Ventilation for Pseudocholinesterase Deficiency

Patients with this rare genetic disorder lack the enzyme needed to break down standard paralyzing drugs (like succinylcholine) used during surgery. Instead of waking up and breathing on their own after 10 minutes, their breathing muscles remain paralyzed for hours. Dr. Roy instantly recognizes this crisis, transitions the patient seamlessly to the ICU, and expertly manages prolonged mechanical ventilation until the drug naturally wears off, preventing brain damage from oxygen deprivation.

Massive Burn Resuscitation & ICU Care

Severe burns covering large areas of the body cause massive fluid loss, extreme temperature drops (hypothermia), and agonizing pain. In the ICU, Dr. Roy utilizes complex mathematical formulas (like the Parkland formula) to calculate and deliver massive volumes of intravenous fluids, maintains strict infection control, regulates core body temperature, and utilizes her Pain Control Management (PCM) training to keep the patient sedated and comfortable during agonizing dressing changes.

Condition-Specific Deep Dives

Pseudocholinesterase Deficiency

A silent, inherited genetic disorder that typically goes completely unnoticed until the patient has their first major surgery. When given specific muscle relaxants to place a breathing tube, the patient's body cannot metabolize the drug. It is a terrifying scenario where the patient may regain consciousness but remain completely physically paralyzed and unable to breathe. It requires a highly observant anesthesiologist to keep the patient sedated and mechanically ventilated until the paralysis subsides.

Acute Porphyria in Anesthesia

Porphyrias are a group of rare genetic disorders affecting the nervous system and skin. In patients with acute porphyria, exposure to very common anesthetic drugs (like Thiopental or certain sedatives) acts as a trigger. It causes a massive, toxic buildup of porphyrins, resulting in a severe "crisis" characterized by extreme abdominal pain, seizures, and rapid, life-threatening paralysis of the breathing muscles. Dr. Roy must meticulously hand-pick a completely customized, safe combination of anesthetic drugs.

Neonatal Congenital Anesthesia

Administering anesthesia to a newborn baby—especially one born with severe birth defects (like a hole in the diaphragm or exposed intestines)—is one of the most challenging feats in medicine. A neonate's airway is just millimeters wide, their blood volume is barely a cup, and they lose body heat instantly. Dr. Roy uses microscopic precision to insert breathing tubes, calculate drug doses in micrograms, and monitor the baby's fragile heart every single second during surgery.

The Doctor’s Clinical Approach

Dr. Lipika Roy utilizes over 12 years of profound clinical wisdom, navigating the razor-thin margins of error in the ICU and operating rooms. Her philosophy emphasizes extreme vigilance and exhaustive pre-operative genetic/family history screening to prevent intraoperative disasters, absolute precision in managing high-stakes cardiovascular shifts during tumor removals, and deeply compassionate, 24/7 life-support management for critically ill patients in the HDU.

Specialized Risk Factors

Emergency Callout: Immediate emergency medical intervention is required if a patient under anesthesia develops sudden, severe flushing of the face, wheezing, and a catastrophic drop in blood pressure (Carcinoid Crisis), a patient fails to start breathing on their own hours after a routine surgery is completed (suspected Pseudocholinesterase deficiency), or a severe burn victim experiences a sudden drop in urine output and confusion (Burn Shock / fluid depletion).

Certifications & Professional Memberships

• Member, Bangladesh Medical and Dental Council (BMDC)

• Member, Bangladesh Society of Anaesthesiologists (BSA)

• Consultant, ICU & Anesthesiology, BCS (Health) Cadre

• MD in Anesthesiology with Special Training in ICU & PCM

Patient Visit Preparation Checklist

• Crucial for Surgery: Adhere strictly to the "NPO" (Nil Per Os) fasting guidelines provided by the hospital—do not eat or drink anything for the specified hours before surgery to prevent fatal aspiration.

• If you have ever taken hours to wake up from anesthesia, or if anyone in your family has a history of severe reactions to anesthesia or a diagnosis of Porphyria, you MUST inform Dr. Roy immediately.

• Bring a complete, detailed list of all current medications, especially blood pressure drugs, asthma inhalers, and any psychiatric medications.

• For ICU family members, designate one primary spokesperson to receive medical updates from Dr. Roy to ensure clear, consistent communication regarding the patient's critical status.

Last Modified: October 29, 2026